Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience
Language English Country Germany Media print-electronic
Document type Evaluation Study, Journal Article
- MeSH
- Equipment Safety MeSH
- Time Factors MeSH
- Equipment Design MeSH
- Adult MeSH
- Prosthesis-Related Infections etiology MeSH
- Escherichia coli Infections complications MeSH
- Catheterization, Central Venous adverse effects instrumentation MeSH
- Middle Aged MeSH
- Humans MeSH
- Foreign-Body Migration etiology MeSH
- Neoplasms drug therapy MeSH
- Follow-Up Studies MeSH
- Device Removal MeSH
- Antineoplastic Agents administration & dosage MeSH
- Pseudomonas Infections complications MeSH
- Aged MeSH
- Sepsis etiology MeSH
- Jugular Veins surgery MeSH
- Ulcer etiology MeSH
- Treatment Outcome MeSH
- Catheters, Indwelling adverse effects MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Names of Substances
- Antineoplastic Agents MeSH
AIM OF WORK: Evaluation of suitability and safety of venous port implantation with catheter insertion via the right internal jugular vein in oncology patients. PATIENTS AND METHODS: One hundred one totally implantable venous ports were placed in 100 patients with malignancies from January 1, 2003 until March 31, 2005. Catheter of venous port was preferably inserted via the right internal jugular vein. We recorded a number of successful implantations using this venous approach and the rate of complications during the procedure and follow-up. MAIN RESULTS: Ninety-seven catheters (96%) of totally implantable venous ports were inserted via the right internal jugular vein in 96 patients, and only in four cases were we not able to access this vein. We had no complications related to catheter insertion via the right internal jugular vein. Follow-up was made in all 96 patients with a total access days of 41 in 151 days (mean: 407 days). Premature catheter removal was required in six (6.2%, 0.144 per 1,000 access days) due to complications: three catheter dislocations/malfunctions (3.1%, 0.072 per 1,000 access days), one port-related sepsis, one pocket port infection, and one decubitus over port (1%, 0.024 per 1,000 access days). Six venous ports were removed after completion of the treatment at the patient's request. CONCLUSION: The placement of totally implantable venous ports with catheter insertion via the right internal jugular vein has a high success rate without any early complications. Follow-up also demonstrates a low incidence of late complications requiring port removal.
See more in PubMed
J Vasc Interv Radiol. 1997 Nov-Dec;8(6):991-5 PubMed
Radiology. 1992 Jul;184(1):149-51 PubMed
Acta Oncol. 1999;38(8):1103-7 PubMed
Am J Med. 1982 Dec;73(6):841-5 PubMed
J Clin Oncol. 1999 Apr;17(4):1267 PubMed
Surg Gynecol Obstet. 1979 Jun;148(6):871-5 PubMed
Ann Oncol. 1998 Jul;9(7):767-73 PubMed
World J Surg. 1998 Jan;22(1):12-6 PubMed
Thromb Haemost. 1996 Feb;75(2):251-3 PubMed
AJR Am J Roentgenol. 1997 Nov;169(5):1431-4 PubMed
Surg Gynecol Obstet. 1973 Apr;136(4):602-6 PubMed
Eur Radiol. 1996;6(5):748-52 PubMed
Eur J Cancer Clin Oncol. 1989 Jun;25(6):939-44 PubMed
J Neurosurg Anesthesiol. 1996 Oct;8(4):286-92 PubMed
Cardiovasc Intervent Radiol. 1997 Jan-Feb;20(1):17-22 PubMed
AJR Am J Roentgenol. 2001 Apr;176(4):991-4 PubMed
Br J Cancer. 1996 May;73(10):1260-4 PubMed
Acta Radiol. 2002 Jul;43(4):371-5 PubMed
